Overview

• The Health Benefit Assessment Dashboard estimates nationwide disease prevalence could fall to 3.09% from 4.87% if PM2.5 is reduced by 30% in line with the earlier NCAP benchmark.
• Modelled declines include heart disease among women by 3%–10%, diabetes by 8%–25%, hypertension by 2%–8%, and COPD by 3%–12%, with benefits varying by region.
• Projected gains are largest across the Indo-Gangetic plain and eastern India, with pronounced improvements flagged for Assam, Jammu & Kashmir, and Nagaland.
• For children under five, the tool projects measurable drops in lower respiratory infections, low birth weight, and anaemia, with the steepest respiratory reductions in Bihar, Delhi, Odisha, and Jharkhand.
• The dashboard synthesizes NFHS‑5 prevalence data, Indian epidemiological studies, and satellite PM2.5 on 2011 district boundaries, assumes a uniform 30% reduction, and is intended to guide policy within the NCAP context.